like so many other biological substances, was discovered incidentally. William 11. llowell, professor of physiology at Johns 11opkinis University, Baltimore, was in 1916 trying to isolate a thromboplastin, an accelerator of the coagulation of the blood, from the phosphatide fraction of the liver and the heart. His co-worker, Jay AMcLean, found instead a substance, later called heparin, which retarded the coagulation of blood. Also unexpected was the finding made almost 20 years later in 1935 that heparin is a mucopolysaceharide esterified with sulfuric acid to a quite extraordinary degree. dry substance of the purest heparin preparations.
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The Chem)ical AN atuire of Heparin
The closest chemical neighbor of heparin, chondroitin sulfurie acid, was in the 1920 's in spite of its interesting chemical composition still not easily accessible. It shared with the nueleic acids the property of being a macromolecular ester of a strong mineral acid, in this case sulfuric acid. In 1928, I succeeded in obtaininig a protein-free chondroitin sulfuric acid having an almost theoretical content of ester sulfate by adsorbing the proteins on kaolin. This preparation was then used in our laboratory as a reference substance for clheckinig the methods used for the quantitative analysis of uronic acids.
Amoncg other natural products analyzed for uronic acids we also included in 1934 the heparini, claimed by llowell to give a positive color reaction for uronic acid. Heparin had been isolated in 1933 in a highly purified state by Charles and Scott of Toronto. In fact, the Tollens-Lefevre technic showed a considerable content of uronic acid in heparin, a content which increased with increasing anticoagulant activity, makingy up almost 20 per cent of the dry substance of the purest heparin preparations.
The Tollens-Lefevre technic is quite reliable and is easy to perform. The same could not be said about the methods applied for the biological assay of heparin. Cats were not so easy to get, and it was difficult to find the operating room and the assistants needed. An easier solution was then found. Series of test tubes containing a glass bead and serial dilutions of heparin solutions were filled early in the morning with fresh ox blood at the slaughter house, and readings of the coagulation times were made at intervals during the day. In 1 day several heparin samples of unknown strength could be compared with a standard heparin practically without any cost. This technic opened the field for further experimentation on a larger scale.
The purified heparin samples were found to contain large quantities of a hexosamine, whieh was later shown to be glucosamine, amounting to one mole of hexosamine per mole of uronic acid. At that time, 1933, Elson As a result of the lively interest in heparin following Crafoord 's first publication in the spring of 1937 on prophylactic heparin treatment in man and our discovery of the connection between heparin and the mast cells of the same year, a physician in Stockholm, Holmin, later in the year tried the new remedy in a case of fresh acute thrombosis in the central retinal vein in a young person. Well aware of the hopeless prognosis, he gave a tentative dose of pure heparin intravenously 3 to 4 times daily over a period of 10 days beginning on the third day of the illness.
Ploman describes the course of this case as quite unusual, for the patient regained a visual acuity of 0.9 in 9 days. In a second case, described by Bostrdm and William-Olsson, where the lesion was 1 month old, visual acuity rose from 0.1 to 0.4 in 5 days and later to 0.6. The unusual course of these 2 consecutive cases made these ophthalmologists inclined to ascribe the result to the treatment with heparin.
In the same year M~agiiussoii (1938) used heparin successfully in a case of thrombosis of the posterior inferior cerebellar artery, Wallenberg's syndrome, a disease in which a regression is unusual. In 1938, Murray and Best reported 28 cases of spontaneous thrombophlebitis and 7 cases of pulmonary embolism treated with heparin. All the cases of embolism showed rapid clinical improvement, and the 28 cases of spontaneous thrombophlebitis showed no evidence of embolism, and the clinical signs and symptoms, pain, swelling, tenderness and fever, appeared to show more rapid improvement than in a control group.
In his second paper Crafoord (1939) Ill speaking about the cradle of heparin it is not out of place to mention that the writer had the pleasure of being able to inform William II. howell of Johns Hopkins University during his last years about the successful progress of the anticoagulant therapy in this part of the world. Needless to say, these reports were welcome. They told him that something of permanent value will remain as a result of his contributions to physiology. They might also to some extent have enlightened those (lark days during the war, as that of April 11, 1942 , when he wrote, ''When this killing and shooting is all over I fear that this world will not be such a pleasant place to live in as it was in my youth-and I shall have no great regrets in leaving it, although
